Involvement of ribonucleotide reductase in cellular differentiation

Area of Science:

• Cell Biology
• Biochemistry
• Molecular Biology

Background:

• L6 and L8 rat myoblast cell lines are used to study muscle cell differentiation.
• Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis by targeting ribonucleotide reductase.
• Myogenic capacity refers to the ability of cells to differentiate into muscle cells.

Purpose of the Study:

• To investigate the role of ribonucleotide reductase in cellular differentiation.
• To determine if drug resistance to hydroxyurea affects myogenic capacity in rat myoblast cell lines.
• To explore the correlation between altered ribonucleotide reductase activity and changes in myogenic potential.

Main Methods:

• Selection of L6 and L8 rat myoblast cell lines for resistance to hydroxyurea.
• Analysis of ribonucleotide reductase activity using velocity and product pool assays.
• Assessment of myogenic capacity in drug-resistant and parental cell lines.

Main Results:

• Hydroxyurea-resistant cell lines displayed significantly altered or absent myogenic capacity compared to parental lines.
• A strong correlation was observed between changes in ribonucleotide reductase activity and impaired myogenic potential.
• Deoxyribonucleoside triphosphate pools were also found to be altered in resistant cell lines.

Conclusions:

• Alterations in ribonucleotide reductase activity and deoxyribonucleoside triphosphate pools can negatively impact cellular differentiation.
• This study provides the first evidence linking modifications in this key DNA synthesis enzyme to impaired myogenic potential.
• These findings suggest a critical role for DNA synthesis regulation in the process of muscle cell differentiation.